Dates: Saturday, September 9, 2023 - Wednesday, September 13, 2023 Venue: MiCo Milan,Milan,Italy The ERS International Congress is the world's largest meeting in the respiratory field. A wealth of new information on all aspects of respiratory health and disease will be presented from experts ...
ERS International Congress 2023: highlights from the Epidemiology and Environment AssemblyThe authors 2024.In this article, early career members of the Epidemiology and Environment Assembly of the European Respiratory Society (ERS) summarise a selection of four poster and oral sessions from the ERS ...
2023年9月9日-13日在意大利米兰举行的世界最大、最具影响力的欧洲呼吸学会国际大会(European Respiratory Society International Congress,以下简称ERS)上苏州吉美瑞生医学科技有限公司(Regend Therapeutics) (以下简称吉美瑞生),一家致力于器官功能再生疗法...
MIRACLE) [Poster Session]. Presented at the European Respiratory Society (ERS) International Congress 2023 (9-13 September).Huang K, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019; 394: 407-418. AstraZeneca plc. H1 and Q2...
[3] Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2023. Updated May 2023. Available from: www.ginasthma.org [4] ERS INTERNATIONAL CONGRESS 2023 PROGRAMME.
European Respiratory Society (ERS) International Congress Dates: Saturday, September 27, 2025 - Wednesday, October 1, 2025 Venue: RAI Amsterdam,Amsterdam,Netherlands The ERS International Congress is the world's largest meeting in the respiratory field. A wealth of new information on all aspects of...
Lommatzsch, M, et al. Durability of Benralizumab-induced remission in severe asthma: an analysis of the BORA study [Oral Presentation]. Presented at the European Respiratory Society (ERS) International Congress 2023 (9-13 September).
2023年9月9日-13日,世界最大、最具影响力的欧洲呼吸学会国际大会(European Respiratory Society International Congress,以下简称ERS)在意大利米兰举行。上海洛启生物医药技术有限公司以口头汇报的形式公布了LQ036治疗哮喘的临床研究结果。LQ036是洛启生物自主研发的抗IL-4Rα纳米抗体药物,也是全球首个进入临床试验的靶向IL...
2024年6月6日,苏州吉美瑞生医学科技有限公司(Regend Therapeutics) (以下简称吉美瑞生)宣布,将于2024年9月9日-10日在2024欧洲呼吸学会国际大会(European Respiratory Society International Congress,以下简称ERS)以新闻发布会和口头汇报双重形式向全球公布自主研发的全球首创肺前体细胞产品REGEND001治疗特发性肺纤维化(IPF...
ERS International Congress 2024: Vienna ERS 2024-欧洲呼吸年会-ERS欧洲呼吸年会-ERS国际大会-2024ERS年会-欧洲呼吸学会年会-维也纳 ◆ 参会对象: 呼吸科医生,外科医生,重症监护医生,护士,医院管理者、呼吸科主任、副主任、医生及从事该领域研究的专家、科研人员、医药企业等。